Drug
Weifuchun
Weifuchun is a pharmaceutical drug with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Phase Distribution
Ph early_phase_1
2
67%
Ph phase_4
1
33%
Phase Distribution
2
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Early Phase 1First-in-human
2(66.7%)
Phase 4Post-market surveillance
1(33.3%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(1)
Other(1)
Detailed Status
unknown1
Completed1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Early Phase 12 (66.7%)
Phase 41 (33.3%)
Trials by Status
unknown133%
completed133%
recruiting133%
Recent Activity
1 active trials
Showing 3 of 3
recruitingphase_4
Efficacy and Safety of Weifuchun Tablet in Reversing Gastric Intestinal Metaplasia
NCT06610266
completedearly_phase_1
Clinical Study of Weifuchun Treatment on Gastric Cancer
NCT05888675
unknownearly_phase_1
Clinical Study of Weifuchun Treatment on Precancerous Lesions of Gastric Cancer
NCT03814629
Clinical Trials (3)
Showing 3 of 3 trials
NCT06610266Phase 4
Efficacy and Safety of Weifuchun Tablet in Reversing Gastric Intestinal Metaplasia
NCT05888675Early Phase 1
Clinical Study of Weifuchun Treatment on Gastric Cancer
NCT03814629Early Phase 1
Clinical Study of Weifuchun Treatment on Precancerous Lesions of Gastric Cancer
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3